The Global Pharmaceutical Contract Manufacturing Market is Expected to Reach an Estimated $297 Billion by 2030
The Global Pharmaceutical Contract Manufacturing Market is Expected to Reach an Estimated $297 Billion by 2030
Blog Article
According to a market report by Lucintel, the future of the global pharmaceutical contract manufacturing market looks promising with opportunities in the big pharmaceutical, small & medium-sized pharmaceutical, generic pharmaceutical, others markets. The global pharmaceutical contract manufacturing market is expected to reach an estimated $297 billion by 2030 at a CAGR of 8% from 2024 to 2030. The major drivers for this market are pharmaceutical companies seek cost-effective solutions for manufacturing, driving demand for contract manufacturing services to reduce operational and production costs., companies outsource manufacturing to focus on core activities like r&d and marketing, allowing them to leverage specialized manufacturing expertise., and the ability to quickly scale production up or down based on demand provides pharmaceutical companies with greater flexibility and efficiency.
In this market, manufacturing, drug development, biologics manufacturing are the major segments of pharmaceutical contract manufacturing market by type.
Lucintel forecasts that big pharmaceutical will remain the largest segment over the forecast period.
Within this market, biologics manufacturing will remain the largest segment.
North America will remain the largest region over the forecast period.
Thermo Fisher Scientific, Catalent, Lonza, Almac Group, Recipharm, Patheon, and Grifols International are the major suppliers in the pharmaceutical contract manufacturing market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cast visit Lucintel’s Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1 972.636.5056